Matches in Wikidata for { <http://www.wikidata.org/entity/Q96143282> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q96143282 description "clinical trial" @default.
- Q96143282 description "ensayo clínico" @default.
- Q96143282 description "ensayu clínicu" @default.
- Q96143282 description "klinisch onderzoek" @default.
- Q96143282 description "клінічне випробування" @default.
- Q96143282 description "临床试验" @default.
- Q96143282 name "A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes" @default.
- Q96143282 name "A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes" @default.
- Q96143282 type Item @default.
- Q96143282 label "A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes" @default.
- Q96143282 label "A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes" @default.
- Q96143282 prefLabel "A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes" @default.
- Q96143282 prefLabel "A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes" @default.
- Q96143282 P1050 Q96143282-B4D8FC9D-4831-40E2-9873-51F5767F5269 @default.
- Q96143282 P1132 Q96143282-287386E3-F952-4D75-A9A3-18C2C2CC7B01 @default.
- Q96143282 P1476 Q96143282-9E38C308-CF2E-43FC-8E13-671C03510CB8 @default.
- Q96143282 P17 Q96143282-7ED3550A-A3D4-4EDC-BF35-8E9CA68F0732 @default.
- Q96143282 P2899 Q96143282-42E55FFA-44AD-43DB-9865-36DBC644EC43 @default.
- Q96143282 P3098 Q96143282-FA837B9E-7524-4B62-9EB1-043CAF0C797D @default.
- Q96143282 P31 Q96143282-B6CEF489-079F-4AF2-A867-B2883E605FC9 @default.
- Q96143282 P580 Q96143282-AB309670-7096-43F0-BFDA-52DA0F3C78AB @default.
- Q96143282 P582 Q96143282-2CC12B4C-C71B-46C0-949B-0281F0598B22 @default.
- Q96143282 P6099 Q96143282-60871DDD-F753-4A02-9C7B-5CDD4D0B14A4 @default.
- Q96143282 P8005 Q96143282-BB33ADF8-0E8F-46C5-95A4-638BE903D0AF @default.
- Q96143282 P8363 Q96143282-20DB8BB4-B9B5-493E-9E93-72A10F5FB5D0 @default.
- Q96143282 P1050 Q179630 @default.
- Q96143282 P1132 "+54" @default.
- Q96143282 P1476 "A Phase 2, Open-Label, Ascending Dose Study of KER-050 for the Treatment of Anemia in Patients With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)" @default.
- Q96143282 P17 Q408 @default.
- Q96143282 P2899 "+18" @default.
- Q96143282 P3098 "NCT04419649" @default.
- Q96143282 P31 Q30612 @default.
- Q96143282 P580 "2020-09-15T00:00:00Z" @default.
- Q96143282 P582 "2022-01-31T00:00:00Z" @default.
- Q96143282 P6099 Q42824440 @default.
- Q96143282 P8005 Q76649708 @default.
- Q96143282 P8363 Q78089383 @default.